Human abuse liability assessment of oxycodone combined with ultra-low-dose naltrexone

Overview of attention for article published in Psychopharmacology, April 2010

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (66th percentile)
Above-average Attention Score compared to outputs of the same age and source (59th percentile)

Mentioned by

twitter: 1 X user

patent: 29 patents

Citations

dimensions_citation: 25 Dimensions

Readers on

mendeley: 49 Mendeley

So far, Altmetric has seen 29 patents that reference this research output.

Human abuse liability assessment of oxycodone combined with ultra-low-dose naltrexone

About this Attention Score

Mentioned by

Citations

Readers on

Abuse-proofed oral dosage form

Grant US-11844865-B2

United States of America

Process for the production of an abuse-proofed dosage form

Grant US-11224576-B2

United States of America

Tamper-resistant tablet providing immediate drug release

Grant US-10864164-B2

United States of America

Protecting oral overdose with abuse deterrent immediate release formulations

Grant US-10842750-B2

United States of America

Process for the production of an abuse-proofed dosage form

Grant US-10729658-B2

United States of America

Tamper-resistant tablet providing immediate drug release

Grant US-10695297-B2

United States of America

Crush resistant delayed-release dosage forms

Grant US-10675278-B2

United States of America

Tamper-resistant dosage form containing ethylene-vinyl acetate polymer

Grant US-10624862-B2

United States of America

Oxidation-stabilized tamper-resistant dosage form

Grant US-10493033-B2

United States of America

Preparation of a powdery pharmaceutical composition by means of cryo-milling

Grant US-10449547-B2

United States of America

Abuse-proofed dosage form

Grant US-10369109-B2

United States of America

Tamper resistant and dose-dumping resistant pharmaceutical dosage form

Grant US-10335373-B2

United States of America

Tamper resistant dosage form comprising inorganic salt

Grant US-10300141-B2

United States of America

Tamper-resistant dosage form containing one or more particles

Grant US-10154966-B2

United States of America

Abuse-proofed dosage form

Grant US-10130591-B2

United States of America

Hot-melt extruded pharmaceutical dosage form

Grant US-10080721-B2

United States of America

Thermoformed, tamper-resistant pharmaceutical dosage form containing zinc

Grant US-10064945-B2

United States of America

Abuse-proofed dosage form

Grant US-10058548-B2

United States of America

Oxidation-stabilized tamper-resistant dosage form

Grant US-9925146-B2

United States of America

Tamper resistant immediate release capsule formulation comprising tapentadol

Grant US-9913814-B2

United States of America

Multiparticles safeguarded against ethanolic dose-dumping

Grant US-9872835-B2

United States of America

Tamper-resistant dosage form with immediate release and resistance against solvent…

Grant US-9855263-B2

United States of America

Pharmaceutical dosage form

Grant US-9750701-B2

United States of America

Tamper resistant dosage form with bimodal release profile

Grant US-9737490-B2

United States of America

Abuse-proofed dosage form

Grant US-9675610-B2

United States of America